Take action to slow GA

SYFOVRE is the longest-studied FDA-approved treatment for GA, studied in


2 clinical trials with

1,200 people and over

10,000 treatments given

SYFOVRE was proven to slow lesion growth in people treated with SYFOVRE versus those who were not.

Trial 1

After 2 years, compared to those who did not receive SYFOVRE, SYFOVRE slowed lesion growth by

22 %
when taken
monthly

(n=202)
18 %
when taken
every other month

(n=205)
 

Trial 2

After 2 years, compared to those who did not receive SYFOVRE, SYFOVRE slowed lesion growth by

18 %
when taken
monthly

(n=201)
17 %
when taken
every other month

(n=201)

GA cannot be cured, and the damage cannot be reversed. However, slowing lesion growth can delay disease progression.

When GA threatens your eyes, act now to slow GA with SYFOVRE.